ARTICLE | Financial News
ReNeuron aims for AIM IPO
October 9, 2000 7:00 AM UTC
ReNeuron (London, U.K.), which specializes in using brain stem cells to treat neurological disorders, said it will seek a listing on AIM in November. WestLB Panmure is the advisor and broker. ...